In the recent past there have been calls for a GSA. However as I have previously maintained the pipeline is the most critical to a successful outcome. APA have indicated pipeline cost approx. $800m and regardless of any desire to enter into a GSA interested parties would need a guarantee that molecules would flow. So just on the pipeline cost at $800m this could conceivably be more than any asset sale value (approx. 80c per share).
BUL Price at posting:
12.5¢ Sentiment: Buy Disclosure: Held
